Jardiance and Somavert drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Jardiance (empagliflozin) and Somavert (pegvisomant). Common drug interactions include insulin-like growth factor increased among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Jardiance and Somavert. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Jardiance?

Jardiance has active ingredients of empagliflozin. It is often used in hyperglycemia. eHealthMe is studying from 44,457 Jardiance users. Check the latest studies of Jardiance.

What is Somavert?

Somavert has active ingredients of pegvisomant. eHealthMe is studying from 5,774 Somavert users. Check the latest studies of Somavert.



On Jul, 03, 2026

32 people who take Jardiance and Somavert together, and have interactions are studied.

Jardiance and Somavert drug interactions.

What are the common drug interactions of Jardiance and Somavert, by gender? *:

female:

  1. Insulin-like growth factor increased
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Depression
  4. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  5. Fatigue (feeling of tiredness)
  6. Headache (pain in head)
  7. Nasopharyngitis (inflammation of the nasopharynx)
  8. Neck pain
  9. Rash
  10. Urticaria (rash of round, red welts on the skin that itch intensely)

male:

  1. Diarrhoea
  2. Insulin-like growth factor increased
  3. Back pain
  4. Chest pain
  5. Liver disorder (liver diseases)
  6. Road traffic accident
  7. Fatigue (feeling of tiredness)
  8. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  9. Diabetes mellitus inadequate control
  10. Arthralgia (joint pain)

What are the common drug interactions of Jardiance and Somavert, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Depression
  3. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  4. Fatigue (feeling of tiredness)
  5. Headache (pain in head)
  6. Insulin-like growth factor increased
  7. Nasopharyngitis (inflammation of the nasopharynx)
  8. Neck pain
  9. Rash
  10. Urticaria (rash of round, red welts on the skin that itch intensely)

50-59:

  1. Insulin-like growth factor increased
  2. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  3. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  4. Diabetes mellitus inadequate control
  5. Insulin-like growth factor decreased
  6. Blood glucose increased
  7. Chest pain
  8. Enzyme abnormality
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Constipation

60+:

  1. Diarrhoea
  2. Blood growth hormone increased
  3. Back pain
  4. Chest pain
  5. Liver disorder (liver diseases)
  6. Road traffic accident
  7. Arthralgia (joint pain)
  8. Asthenia (weakness)
  9. Depressed mood
  10. Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

  1. Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 23 people, 71.88%
  2. Diabetes: 10 people, 31.25%
  3. High Blood Pressure: 7 people, 21.88%
  4. Depression: 7 people, 21.88%
  5. Insulin-Like Growth Factor Increased: 6 people, 18.75%
  6. Pituitary Tumor Benign: 4 people, 12.50%
  7. Diarrhea: 3 people, 9.38%
  8. Type 2 Diabetes: 2 people, 6.25%
  9. Renal Disorder (kidney disease): 2 people, 6.25%
  10. Parkinson's Disease: 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Jardiance and Somavert?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Jardiance and Somavert:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Jardiance:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Somavert:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Jardiance and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Somavert and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on empagliflozin and pegvisomant (the active ingredients of Jardiance and Somavert, respectively), and Jardiance and Somavert (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: